We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$685M
2
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$54.5M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$42.1M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$27.7M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 11.56%
3 Healthcare 11.43%
4 Consumer Discretionary 10.98%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTBA icon
3076
West Bancorporation
WTBA
$508M
$53K ﹤0.01%
2,221
-237
-10% -$5.39K
AGR
3077
DELISTED
Avangrid, Inc.
AGR
$53K ﹤0.01%
1,070
-3,169
-75% -$149K
YTEN
3078
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$53K ﹤0.01%
177
+130
+277% +$44K
RVLP
3079
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$53K ﹤0.01%
16,116
+12,233
+315% +$50.3K
CNCE
3080
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$53K ﹤0.01%
10,691
+5,224
+96% +$42.2K
AIRT icon
3081
Air T
AIRT
$80.7M
$52K ﹤0.01%
2,189
+510
+30% +$12.7K
ATRO icon
3082
Astronics
ATRO
$4.57B
$52K ﹤0.01%
3,486
+2,657
+321% +$34.4K
BKD icon
3083
Brookdale Senior Living
BKD
$3.04B
$52K ﹤0.01%
8,509
-48,877
-85% -$263K
CVE icon
3084
Cenovus Energy
CVE
$57.7B
$52K ﹤0.01%
6,986
+3,337
+91% +$23.4K
EWN icon
3085
iShares MSCI Netherlands ETF
EWN
$736M
$52K ﹤0.01%
1,128
-736
-39% -$32.6K
EZPW icon
3086
Ezcorp Inc
EZPW
$1.79B
$52K ﹤0.01%
10,504
-828
-7% -$4.16K
JBSS icon
3087
John B. Sanfilippo & Son
JBSS
$1.01B
$52K ﹤0.01%
576
+143
+33% +$12.4K
LGHL
3088
Lion Group Holding
LGHL
$680K
– –
0
– –
LPRO
3089
DELISTED
Open Lending Corp
LPRO
$52K ﹤0.01%
1,468
+1,391
+1,806% +$52.5K
MITT
3090
TPG Mortgage Investment Trust
MITT
$215M
$52K ﹤0.01%
+4,330
New +$49.2K
OPRX icon
3091
OptimizeRx
OPRX
$165M
$52K ﹤0.01%
1,071
-3,146
-75% -$152K
PDS
3092
Precision Drilling
PDS
$1.09B
$52K ﹤0.01%
2,424
-10,664
-81% -$242K
SPOK icon
3093
Spok Holdings
SPOK
$230M
$52K ﹤0.01%
4,950
+1,304
+36% +$14.9K
TCMD icon
3094
Tactile Systems Technology
TCMD
$545M
$52K ﹤0.01%
951
+485
+104% +$26K
VATE icon
3095
INNOVATE Corp
VATE
$104M
$52K ﹤0.01%
1,308
-1,246
-49% -$46.3K
ARCE
3096
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$52K ﹤0.01%
2,048
+1,735
+554% +$59K
ICPT
3097
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$52K ﹤0.01%
2,251
-7,561
-77% -$211K
JNCE
3098
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$52K ﹤0.01%
5,072
-9,849
-66% -$108K
TSC
3099
DELISTED
TriState Capital Holdings, Inc.
TSC
$52K ﹤0.01%
2,253
+925
+70% +$20.5K
ACAD icon
3100
Acadia Pharmaceuticals
ACAD
$4.85B
$51K ﹤0.01%
1,960
-18,568
-90% -$817K
122 123
124
125 126

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.